VisionPoint Advisory Group’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.49M Sell
18,105
-1,049
-5% -$87.7K 0.23% 94
2026
Q2
$1.58M Sell
19,154
-1,090
-5% -$87.5K 0.26% 94
2026
Q1
$1.53M Sell
20,244
-275
-1% -$21.5K 0.29% 87
2025
Q4
$1.54M Sell
20,519
-1,364
-6% -$102K 0.3% 88
2025
Q3
$1.61M Sell
21,883
-115
-0.5% -$8.25K 0.32% 85
2025
Q2
$1.56M Buy
+21,998
New +$1.47M 0.34% 83

Other funds holding JIRE

VisionPoint Advisory Group's JIRE Position: Q3 2026 in Review

VisionPoint Advisory Group reduced its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 5.5% in Q3 2026, selling an estimated $87.7K and leaving 18,105 shares worth $1.49M. The position accounts for 0.23% of the portfolio, ranked #94.

VisionPoint Advisory Group first reported a position in JIRE in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.61M in Q3 2025. 72 funds tracked by Wall St. Rank hold JIRE as of Q3 2026.

  • VisionPoint Advisory Group held 18,105 shares of JPMorgan International Research Enhanced Equity ETF worth $1.49M as of Q3 2026.
  • VisionPoint Advisory Group sold 1,049 JPMorgan International Research Enhanced Equity ETF shares in Q3 2026, an estimated $87.7K.
  • JPMorgan International Research Enhanced Equity ETF made up 0.23% of VisionPoint Advisory Group's portfolio in Q3 2026, its #94 holding.
  • VisionPoint Advisory Group first reported a position in JPMorgan International Research Enhanced Equity ETF in Q2 2025 and has held it in 6 quarters since.
  • VisionPoint Advisory Group's JPMorgan International Research Enhanced Equity ETF position peaked at $1.61M in Q3 2025.
  • 72 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q3 2026.

Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.